Open Access. Powered by Scholars. Published by Universities.®
Physical Sciences and Mathematics Commons™
Open Access. Powered by Scholars. Published by Universities.®
Articles 1 - 2 of 2
Full-Text Articles in Physical Sciences and Mathematics
In Vitro And In Vivo Identification And Quantification Of Carmofur And 5-Fluorouracil Using Tandem Mass Spectrometry, Mohammad Mohiminul Islam
In Vitro And In Vivo Identification And Quantification Of Carmofur And 5-Fluorouracil Using Tandem Mass Spectrometry, Mohammad Mohiminul Islam
Theses and Dissertations
Glioblastoma is the most aggressive solid tumor of the brain. Prior studies from our lab found that carmofur, also known as 1-hexylcarbanoyl 5-fluorouracil (HCFU) is a promising candidate in suppressing and killing tumor cell lines compared to the FDA-approved drug temozolomide. Originally developed as pro-drug of 5-fluorouracil (5-FU), carmofur has been in use in clinic for the treatment of colorectal cancer for over four decades in Japan. Having it used in clinics, it has a high probability of repurposing for diseases with no cure such as glioblastoma. Carmofur has also been found effective against other cancers such as head and …
Physicochemical Properties, Pharmacokinetics And Biodistribution Of Arm14988, An Acid Ceramidase Inhibitor, And Its Potential As Chemotherapeutic Agent For Glioblastoma, Vilashini Rajaratnam
Physicochemical Properties, Pharmacokinetics And Biodistribution Of Arm14988, An Acid Ceramidase Inhibitor, And Its Potential As Chemotherapeutic Agent For Glioblastoma, Vilashini Rajaratnam
Theses and Dissertations
Glioblastoma (GBM) is one of the most common and detrimental forms of brain tumor. While there are few FDA-approved chemotherapeutic treatments, the overall survival is still poor leading to many studies dedicated to developing more effective treatment options. Previous studies have identified acid ceramidase (ASAH1) as a potential therapeutic target for this disease. ARN14988, an ASAH1 inhibitor, has shown to be highly cytotoxic compared to the FDA-approved chemotherapy agent, temozolomide, in GBM cell lines. This initial finding makes ARN14988 a desired candidate for further drug discovery studies. Herein, the objective of this thesis is to study the pharmacological properties of …